TRAJENTA

This brand name is authorized in Austria, Australia, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug TRAJENTA contains one active pharmaceutical ingredient (API):

1 Linagliptin UNII 3X29ZEJ4R2 - LINAGLIPTIN

Linagliptin is an inhibitor of the enzyme DPP-4 (dipeptidyl peptidase 4, EC 3.4.14.5) an enzyme which is involved in the inactivation of the incretin hormones GLP-1 and GIP (glucagon-like peptide1, glucose-dependent insulinotropic polypeptide). These hormones are rapidly degraded by the enzyme DPP-4. Both incretin hormones are involved in the physiological regulation of glucose homeostasis. Read about Linagliptin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TRAJENTA Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10BH05		A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors
Discover more medicines within A10BH05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11280Q, 3387G
Country: CA	Health Products and Food Branch	Identifier(s): 02370921
Country: EE	Ravimiamet	Identifier(s): 1539255, 1539266, 1539277, 1539288, 1539299, 1539301, 1539312, 1539323, 1539334, 1539345, 1539356
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 11707004
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 091493, 518897
Country: FR	Base de données publique des médicaments	Identifier(s): 60710236
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 194929, 368937, 368938, 375361, 375362, 381708, 381709
Country: HK	Department of Health Drug Office	Identifier(s): 61383
Country: IE	Health Products Regulatory Authority	Identifier(s): 65482
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7286
Country: IT	Agenzia del Farmaco	Identifier(s): 041401011, 041401023, 041401035, 041401047, 041401050, 041401062, 041401074, 041401086, 041401098, 041401100, 041401112
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1061938, 1061939, 1061940, 1061941, 1061942, 1061943, 1061944, 1061945, 1061946, 1061947, 1061948
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 101125
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 15235
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100252916
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W57301001, W57301002, W57301003, W57301004, W57301005, W57301006, W57301007, W57301008, W57301009, W57301010, W57301011
Country: SG	Health Sciences Authority	Identifier(s): 14101P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 11533061
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699693090041
Country: ZA	Health Products Regulatory Authority	Identifier(s): 45/21.2/0557